HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 286 filers reported holding HAEMONETICS CORP in Q2 2020. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $332,000 | +1.2% | 2,795 | -25.6% | 0.00% | -50.0% |
Q3 2020 | $328,000 | -27.4% | 3,759 | -25.5% | 0.00% | -50.0% |
Q2 2020 | $452,000 | -11.0% | 5,048 | -0.9% | 0.00% | 0.0% |
Q1 2020 | $508,000 | -54.3% | 5,094 | -47.6% | 0.00% | -42.9% |
Q4 2019 | $1,112,000 | +7.5% | 9,720 | +18.5% | 0.01% | 0.0% |
Q3 2019 | $1,034,000 | +19.1% | 8,201 | +13.7% | 0.01% | 0.0% |
Q2 2019 | $868,000 | +4.2% | 7,211 | -25.8% | 0.01% | +40.0% |
Q1 2019 | $833,000 | -57.6% | 9,723 | -50.5% | 0.01% | -37.5% |
Q4 2018 | $1,964,000 | +85.5% | 19,628 | +112.4% | 0.01% | +33.3% |
Q3 2018 | $1,059,000 | -19.3% | 9,240 | -36.9% | 0.01% | -14.3% |
Q2 2018 | $1,313,000 | +17.0% | 14,637 | -4.6% | 0.01% | 0.0% |
Q1 2018 | $1,122,000 | +55.2% | 15,336 | +23.2% | 0.01% | +16.7% |
Q4 2017 | $723,000 | +20.7% | 12,450 | -6.8% | 0.01% | 0.0% |
Q3 2017 | $599,000 | +159.3% | 13,358 | +135.0% | 0.01% | +100.0% |
Q1 2017 | $231,000 | +3.1% | 5,684 | +2.0% | 0.00% | +50.0% |
Q4 2016 | $224,000 | – | 5,575 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |